Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic model for colon adenocarcinoma based on cofactor and vitamin metabolism-related genes. | Transl Cancer Res | 2026 | 41674972 | PubTator, text mining | PubMed |
| Multi-Targeting Effects and Orchestrated Induction of Multiple Cell Death Modalities by Silver-Copper Alloy Nanoparticles Functionalized Drug Nanocrystals in Cancer Cells. | Mol Pharm | 2026 | 41674488 | PubTator, text mining | PubMed |
| DLAT suppresses tumor progression and modulates treatment response in colorectal cancer: Insights from a metabolic prognostic model. | Exp Cell Res | 2026 | 41672292 | PubTator, text mining | PubMed |
| Harnessing AI to fuse phenotypic signatures for drug target identification: progress in computational modeling. | Brief Bioinform | 2026 | 41662351 | PubTator, text mining | PubMed |
| Primary Biliary Cholangitis-associated Osteoporosis: Contemporary Review of Pathogenesis and Management. | J Clin Transl Hepatol | 2026 | 41660001 | PubTator, text mining | PubMed |
| Dynamically Reprograms Mitochondrial Respiration to Augment Cuproptosis in Cancer Therapy. | Small | 2026 | 41653427 | PubTator, text mining | PubMed |
| A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis. | PLoS One | 2026 | 41650163 | PubTator, text mining | PubMed |
| Plasma anti-DLAT autoantibody as a novel diagnostic biomarker in breast cancer. | Clin Immunol | 2026 | 41643757 | PubTator, text mining | PubMed |
| Determinants of culinary Students' Entrepreneurial Intentions: The role of social media use within dual-theory frameworks. | PLoS One | 2026 | 41642905 | PubTator, text mining | PubMed |
| Factors associated with clinical coders' intention to use the international classification of diseases 11th revision (ICD-11): a cross-sectional study in Iran. | BMC Med Inform Decis Mak | 2026 | 41639704 | PubTator, text mining | PubMed |
| Simulation-based assessment of the P-glycoprotein expression-activity relationship shows a drug and system dependency. | J Pharmacokinet Pharmacodyn | 2026 | 41629699 | PubTator, text mining | PubMed |
| Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism. | Int J Oral Sci | 2026 | 41629272 | PubTator, text mining | PubMed |
| Integrated analysis and functional validation reveal KCNQ1 tumor suppressor targeting by dahuang Zhechong Pills via cuproptosis modulation in colorectal cancer. | Comput Biol Chem | 2026 | 41619690 | PubTator, text mining | PubMed |
| Cascade-responsive hydrogen sulfide-releasing nanoplatform for synergistic tumor photothermal-immunotherapy. | J Colloid Interface Sci | 2026 | 41605106 | PubTator, text mining | PubMed |
| IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury. | Liver Int | 2026 | 41603281 | PubTator, text mining | PubMed |
| Behavioral and innovation drivers of farmers' support for forest policy at the forest agriculture interface. | Sci Rep | 2026 | 41593172 | PubTator, text mining | PubMed |
| The mechanism of mandatory exercise check-in on college students' intention to use fitness apps: a complete mediation model. | BMC Psychol | 2026 | 41582124 | PubTator, text mining | PubMed |
| Beyond metabolism: exploring the regulatory and therapeutic implications of lactate and lactylation in cancer-regulated cell death. | Cell Death Dis | 2026 | 41571623 | PubTator, text mining | PubMed |
| Multifunctional nanozyme-mediated synergistic activation of cuproptosis, ferroptosis, and pyroptosis for potent antitumor therapy. | Colloids Surf B Biointerfaces | 2026 | 41544521 | PubTator, text mining | PubMed |
| Cuproptosis of bronchial epithelial cells triggers airway remodeling in chronic asthma. | Sci Rep | 2026 | 41530300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=7